Evidence map›Paper›PMID 12552004›Full record

ArticleJournal of virology2003

E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S.

Denise Perez, Eileen White

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. E1A and E1B proteins inhibit inflammation induced by adenovirus.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Denise PerezCenter for Advanced Biotechnology and Medicine, Department of Molecular Biology and Biochemistry, Rutgers University, 679 Hoes Lane, Piscataway, NJ 08854, USA.
Eileen White
Advanced Pharma · USRutgers, The State University of New Jersey · US

Funding

Function of the Adenovirus E1B OncogeneR37CA053370 · NCI · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI WHITE, EILEEN P. · 2001 to 2009
$3.1M
FUNCTION OF THE ADENOVIRUS E1B ONCOGENER01CA053370 · NCI · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI WHITE, EILEEN · 1991 to 2000
$195k
NCI NIH HHS CA 53370NCI NIH HHS R01 CA053370NCI NIH HHS R37 CA053370
6 · The paper itself

Abstract

Tumor necrosis factor alpha (TNF-alpha) activates both apoptosis and NF-kappaB-dependent survival pathways, the former of which requires inhibition of gene expression to be manifested. c-FLIP is a TNF-alpha-induced gene that inhibits caspase-8 activation during TNF-alpha signaling. Adenovirus infection and E1A expression sensitize cells to TNF-alpha by allowing apoptosis in the absence of inhibitors of gene expression, suggesting that it may be disabling a survival signaling pathway. E1A promoted TNF-alpha-mediated activation of caspase-8, suggesting that sensitivity was occurring at the level of the death-inducing signaling complex. Furthermore, E1A expression downregulated c-FLIP(S) expression and prevented its induction by TNF-alpha. c-FLIP(S) and viral FLIP expression rescued E1A-mediated sensitization to TNF-alpha by restoring the resistance of caspase-8 to activation, thereby preventing cell death. E1A inhibited TNF-alpha-dependent induction of c-FLIP(S) mRNA and stimulated ubiquitination- and proteasome-dependent degradation of c-FLIP(S) protein. Since elevated c-FLIP levels confer resistance to apoptosis and promote tumorigenicity, interference with its induction by NF-kappaB and stimulation of its destruction in the proteasome may provide novel therapeutic approaches for facilitating the elimination of apoptosis-refractory tumor cells.

Indexed as

Down-RegulationIntracellular Signaling Peptides and ProteinsAdenovirus E1A ProteinsAdenoviruses, HumanApoptosisCarrier ProteinsCASP8 and FADD-Like Apoptosis Regulating ProteinCaspase 8Caspase 9CaspasesCysteine EndopeptidasesEnzyme ActivationGene Expression RegulationHeLa CellsHumansMultienzyme ComplexesAdenovirus E1A ProteinsCarrier ProteinsCASP8 and FADD-Like Apoptosis Regulating ProteinCASP8 protein, humanCASP9 protein, humanCaspase 8Caspase 9CaspasesCFLAR protein, humanCysteine EndopeptidasesIntracellular Signaling Peptides and ProteinsMultienzyme ComplexesProteasome Endopeptidase ComplexRNA, MessengerTumor Necrosis Factor-alphaUbiquitin

Identifiers

PMID12552004
PMCPMC141118
OpenAlexW2103618709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.